Skip to content

The clinical effect of new-prescribed LGA-supplement for facial skin of middle-aged and elderly women.

The clinical effect of new-prescribed LGA-supplement for facial skin of middle-aged and elderly women. - Clinical effect of new-prescribed LGA-supplement for ladies.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029830
Enrollment
40
Registered
2017-11-06
Start date
2017-10-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging change in face skin, such as the wrinkles of the eye-corners, the climacteric symptom and/or the weary symptom.

Interventions

Newly compounded LGA supplement, for 2 months. Placebo of the newly compounded LGA supplement, for 2 months.

Sponsors

Plastic and Aesthetic Surgery Dept. Shonan Kamakura General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. The woman with the deep wrinkles, i.e., more than 4 during 8 stages of wrinkles scale. 2. The woman demonstrated more than 40 score in weary awareness score and the climacteric questionnaire, respectively. 3. The woman who isn't taking other supplements currently. 4. The woman who demonstrates written informed consent.

Exclusion criteria

Exclusion criteria: 1. The person who can't participate entirely this clinical trial for 2 months. 2. The person who is not the suitable participant for this trial by the chief study director. 3. Pregnant woman and lactating woman 4. The person who received an other supplement, experimental drug or clinical trial medicine within for 3 months of starting

Design outcomes

Primary

MeasureTime frame
The changes in the wrinkles of eye-corners after 2 months-treatment of the LGA supplement.

Countries

Japan

Contacts

Public ContactShizuhiro Yamada DVM, PhD

Shonan Kamakura General Hospital Center for Clinical and Translational Science

s_yamada@shonankamakura.or.jp0467-46-1717

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026